Kavar Capital Partners Group LLC decreased its stake in BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 34.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 20,250 shares of the company’s stock after selling 10,500 shares during the period. Kavar Capital Partners Group LLC’s holdings in BlackRock Health Sciences Term Trust were worth $292,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds also recently made changes to their positions in BMEZ. Brown Brothers Harriman & Co. bought a new stake in BlackRock Health Sciences Term Trust during the third quarter valued at $32,000. K2 Principal Fund L.P. acquired a new stake in BlackRock Health Sciences Term Trust during the third quarter worth approximately $158,000. Dakota Wealth Management increased its holdings in BlackRock Health Sciences Term Trust by 23.4% in the third quarter. Dakota Wealth Management now owns 22,509 shares of the company’s stock worth $357,000 after purchasing an additional 4,267 shares in the last quarter. Jane Street Group LLC acquired a new position in BlackRock Health Sciences Term Trust in the third quarter valued at approximately $357,000. Finally, Kingswood Wealth Advisors LLC bought a new position in shares of BlackRock Health Sciences Term Trust during the 4th quarter worth approximately $420,000.
BlackRock Health Sciences Term Trust Trading Down 0.1 %
NYSE:BMEZ opened at $16.39 on Monday. BlackRock Health Sciences Term Trust has a twelve month low of $14.27 and a twelve month high of $16.59. The company has a fifty day moving average of $15.29 and a 200-day moving average of $15.61.
BlackRock Health Sciences Term Trust Dividend Announcement
BlackRock Health Sciences Term Trust Profile
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
See Also
- Five stocks we like better than BlackRock Health Sciences Term Trust
- Technology Stocks Explained: Here’s What to Know About Tech
- New Year, New Buybacks: 3 Big-Name Stocks Planning Repurchases
- Stock Sentiment Analysis: How it Works
- Why These 3 Stocks With High Call Option Volume Deserve Attention
- Basic Materials Stocks Investing
- D-Wave: Recent Updates Propel Shares Off 2025 Lows
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.